Abstract
Familial partial lipodystrophy type 2 (FPLD2) is a rare disorder associated with LMNA gene mutations. It is usually marked by loss of subcutaneous fat on the limbs and trunk and severe insulin resistance. Scattered reports have indicated that Roux-en-Y bypass helps to control the diabetes mellitus in these patients. We present here a very unusual patient with FPLD2 who had life-threatening retroperitoneal and renal fat accumulation accompanied by bilateral renal cancers. Following cryotherapy of one renal cancer and a contralateral nephrectomy with debulking of the retroperitoneal fat, Roux-en-Y gastric bypass (RYGB) has successfully controlled the disease for 3 years. The clinical presentations and causes of FPLD are reviewed and the role of RYGB is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Garg A. Clinical review: Lipodystrophies: Genetic and acquired body fat disorders. Journal of Clinical Endocrinology & Metabolism 2011;96:3313–25.
Farhan SM, Robinson JF, McIntyre AD, Marrosu MG, Ticca AF, Loddo S, Carboni N, Brancati F, Hegele RA. A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy. Can J Cardiol 2014;30:1649–54.
Dunnigan M, Cochrane M, Kelly A, Scott J. Familial lipoatrophic diabetes with dominant transmission: A new syndrome. Q J Med 1974;43:33–48.
Köbberling J, Willms B, Kattermann R, Creutzfeldt W. Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik 1975;29:111–20.
Köbberling J, Dunnigan M. Familial partial lipodystrophy: Two types of an X linked dominant syndrome, lethal in the hemizygous state. J Med Genet 1986;23:120–7.
Caron M, Auclair M, Donadille B, Bereziat V, Guerci B, Laville M, Narbonne H, Bodemer C, Lascols O, Capeau J, Vigouroux C. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death & Differentiation 2007;14:1759–67.
Mory PB, Crispim F, Freire MB, Salles JE, Valerio CM, Godoy-Matos AF, Dib SA, Moises RS. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations. European Journal of Endocrinology 2012;167:423–31.
Ji H, Weatherall P, Adams-Huet B, Garg A. Increased skeletal muscle volume in women with familial partial lipodystrophy, Dunnigan variety. Journal of Clinical Endocrinology & Metabolism 2013;98:E1410–3.
Simha V, Rao S, Garg A. Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety. Diabetes Obes Metab 2008;10:1275–6.
Simha V, Subramanyam L, Szczepaniak L, Quittner C, Adams-Huet B, Snell P, Garg A. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety. Journal of Clinical Endocrinology & Metabolism 2012;97:785–92.
McGrath NM, Krishna G. Gastric bypass for insulin resistance due to lipodystrophy. Obesity Surg 2006;16:1542–4.
Utzschneider KM, Trence DL. Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy. Diabetes Care 2006;29:1380–2.
Ciudin A, Baena-Fustegueras JA, Fort JM, Encabo G, Mesa J, Lecube A. Successful treatment for the Dunnigan-type familial partial lipodystrophy with Roux-en-Y gastric bypass. Clin Endocrinol (Oxf) 2011;75:403–4.
Camozzi D, Capanni C, Cenni V, Mattioli E, Columbaro M, Squarzoni S, Lattanzi G. Diverse lamin-dependent mechanisms interact to control chromatin dynamics. Focus on laminopathies. Nucleus (Calc) 2014;5:427–40.
Guenantin AC, Briand N, Bidault G, Afonso P, Bereziat V, Vatier C, Lascols O, Caron-Debarle M, Capeau J, Vigouroux C. Nuclear envelope-related lipodystrophies. Semin Cell Dev Biol 2014;29:148–57.
Araujo-Vilar D, Lattanzi G, Gonzalez-Mendez B, Costa-Freitas AT, Prieto D, Columbaro M, Mattioli E, Victoria B, Martinez-Sanchez N, Ramazanova A, Fraga M, Beiras A, Forteza J, Dominguez-Gerpe L, Calvo C, Lado-Abeal J. Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. J Med Genet 2009;46:40–8.
Haque WA, Vuitch F, Garg A. Post-mortem findings in familial partial lipodystrophy, Dunnigan variety. Diabetic Med 2002;19:1022–5.
Corcelles R, Daigle CR, Schauer PR. Management of endocrine disease: Metabolic effects of bariatric surgery. European Journal of Endocrinology 2016;174:R19–28.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ESH, Nissen SE, Kashyap SR, STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med 2014;370:2002–13.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors listed above meet the criteria of the ICMJE. They have made substantial contributions to the conception or design of the work or the acquisition, analysis, and interpretation of data for the work, and/or drafting or revising it critically for important intellectual content. All authors have given final approval of the version to be published and are accountable for all aspects of it.
Rights and permissions
About this article
Cite this article
Grundfest-Broniatowski, S., Yan, J., Kroh, M. et al. Successful Treatment of an Unusual Case of FPLD2: The Role of Roux-en-Y Gastric Bypass—Case Report and Literature Review. J Gastrointest Surg 21, 739–743 (2017). https://doi.org/10.1007/s11605-016-3300-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-016-3300-2